<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03714126</url>
  </required_header>
  <id_info>
    <org_study_id>CLN0014</org_study_id>
    <nct_id>NCT03714126</nct_id>
  </id_info>
  <brief_title>A Study to Create a Patient Recordings and Clinical Database</brief_title>
  <official_title>A Non-Intervantional Study to Create a Patient Recordings and Clinical Database Using the Cordio System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cordio Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cordio Medical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an observational, non-interventional, prospective, single-arm, open study for
      database establishment for R&amp;D purposes. The study will be conducted in 1 site in Israel with
      up to fifty (50) patients. Patients under hemodialysis supervision will be enrolled in the
      clinical trial. Clinical information for the study will be collected at the hospital and at
      home. The patient will conduct recordings at home every day.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 27, 2019</start_date>
  <completion_date type="Anticipated">March 2021</completion_date>
  <primary_completion_date type="Anticipated">March 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of CHF patients with and without acute lung accumulation. in R&amp;D Database</measure>
    <time_frame>throughout study, upto 60 days per patient</time_frame>
    <description>The objective of the study is to create a recordings database of CHF patients with and without acute lung accumulation.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>HF patients</arm_group_label>
    <description>HF patients will use the Cordio Medical app to record in their hospital visits and at home.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cordio Medical</intervention_name>
    <description>Recording to an app, no interference to the regular care</description>
    <arm_group_label>HF patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Acute and Chronic Congestive Heart Failure patients, undergoing hemodialysis in order to
        balance their volume overload.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing hemodialysis every 5-10 days in order to balance their volume
             overload.

          -  Class C Heart Failure patient with reduced EF CHF (EF&lt;40%) and NYHA 2-3.

          -  Patients with dyspnea clinically related to pulmonary congestion

          -  Patient with more than 3 months HF disease duration.

          -  The patient is willing to participate as evidenced by signing the written informed
             consent.

          -  Male or non-pregnant female patient

        Exclusion Criteria:

          -  Subject who, in the Investigator's opinion, unable to comply with the daily use of the
             App due to mental disorders (e.g., depression, dementia).

          -  Patient who has had a major cardiovascular event (e.g., myocardial infraction, stroke)
             within 3 months prior to screening visit.

          -  Patients likely to undergo heart transplantation/ LVAD within 6 months of Screening
             Visit or baseline functional capacity of NYHA 4.

          -  Patients with evidence of active Infection.

          -  Patient with severe alcohol or drug use.

          -  Psychological instability, inappropriate attitude or motivation.

          -  Patient with life threatening debilitating disease other than cardiac.

          -  Subject currently enrolled in another investigational device or drug trial that has
             not completed the primary endpoint or that clinically interferes with the current
             study endpoints.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Chaim Lotan, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hadassah Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Orit Ronen, MSc</last_name>
    <phone>972-3-5467163</phone>
    <phone_ext>205</phone_ext>
    <email>orit@cordio-med.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hadassah Medical Center</name>
      <address>
        <city>Jerusalem</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chaim Lotan, Prof.</last_name>
      <phone>02-6776564/3</phone>
      <email>lotan@hadassah.org.il</email>
    </contact>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>October 17, 2018</study_first_submitted>
  <study_first_submitted_qc>October 18, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 22, 2018</study_first_posted>
  <last_update_submitted>April 10, 2020</last_update_submitted>
  <last_update_submitted_qc>April 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

